Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Invested Capital (2016 - 2026)

Orthofix Medical has reported Invested Capital over the past 18 years, most recently at $435.2 million for Q1 2026.

  • For the quarter ending Q1 2026, Invested Capital fell 5.04% year-over-year to $435.2 million, compared with a TTM value of $435.2 million through Mar 2026, down 5.04%, and an annual FY2025 reading of $450.0 million, down 11.8% over the prior year.
  • Invested Capital came in at $435.2 million for Q1 2026, down from $450.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $664.2 million in Q1 2023 to a low of $333.5 million in Q3 2022.
  • Median Invested Capital over the past 5 years was $458.3 million (2025), compared with a mean of $487.0 million.
  • The sharpest move saw Invested Capital surged 97.92% in 2023, then fell 20.08% in 2025.
  • Over 5 years, Invested Capital stood at $337.9 million in 2022, then skyrocketed by 77.58% to $600.0 million in 2023, then fell by 14.96% to $510.2 million in 2024, then fell by 11.8% to $450.0 million in 2025, then fell by 3.3% to $435.2 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Invested Capital are $435.2 million (Q1 2026), $450.0 million (Q4 2025), and $442.5 million (Q3 2025).